EGRX - Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tarriff on Q1 2022 Results - Earnings Call Transcript
Eagle Pharmaceuticals, Inc. (EGRX) Q1 2022 Earnings Conference Call May 09, 2022, 08:30 ET Company Participants Lisa Wilson - IR Scott Tarriff - Founder, President, CEO & Director Brian Cahill - CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Lachlan Hanbury-Brown - William Blair & Company David Amsellem - Piper Sandler & Co. Presentation Operator Good morning, everyone. My name is Gretchen, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' First Quarter 2022 Financial Results. [Operator Instructions]. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead. Lisa Wilson Thank you, Gretchen. Welcome to Eco Pharmaceuticals' First Quarter 2022 Earnings Call. This is Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. With me on today's call are Eagle's President and Chief Executive Officer, Scott Tarriff; and Chief
For further details see:
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q1 2022 Results - Earnings Call Transcript